KAHR medical Ltd. announced that it has received $300,000 in a round of funding from returning investors, Hadasit Bio-Holdings Ltd (TASE:HDST) on September 19, 2019. The securities issued in the transaction will convertible into shares in the sum of $7,000,000, date of conversion of investment into its shares is December 31, 2019.